Through our bioanalytical laboratory, Sannova delivers end-to-end support for pharmaceutical development programs. Our expertise spans DMPK assessment, toxicokinetic evaluation, bioanalytical method development and validation, and comprehensive analysis of both preclinical and clinical samples. Operating as a specialized contract research organization, we maintain a suite of sophisticated analytical platforms - including TIMS technology, LC/MS/MS systems, and ICP/MS instrumentation - enabling us to provide highly accurate and sensitive testing services for drug development programs.

Specializing in analytical CRO services, Sannova employs cutting-edge methods to analyze key molecular characteristics including weight, structure, concentration, purity, reactivity, and stability. Our advanced laboratory features industry-leading analytical equipment, from HPLC systems and particle size analyzers to stability chambers to ICP-MS instruments for detecting metal impurities. This comprehensive analytical capability allows clients to accelerate product development, optimize existing formulations, validate safety and effectiveness, release commercial batches, and thoroughly understand how substances perform across different environmental conditions.